Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
Under-the-hood changes in Google's browser - aimed at improving privacy, security, and performance - will reduce the control ...
To counteract emerging cyberthreats posed by artificial intelligence, the baseline level of cybersecurity across society must ...
It is instead content to watch yet another U.S. president spend America’s blood, treasure, ambition, and munitions in the region, and yet another U.S. administration subordinate its China policy to ...
In these 2025 Advanced Life Support Guidelines, the American Heart Association provides comprehensive recommendations for the resuscitation and management of adults experiencing cardiac arrest, ...
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
Sign up for Chalkbeat’s free weekly newsletter to keep up with how education is changing across the U.S. The nation’s 9-year-olds, children who were on the cusp ...
Dr. Brian Kelley, a cardiologist with Novant Health, was in the studio to discuss new treatment advancements that offer additional options for some patients. Blue Cross and Blue Shield of North ...
WILMINGTON, N.C. (AP) - An experimental pill is providing new hope for patients with advanced pancreatic cancer, one of the deadliest malignancies that often shows no early symptoms, according to the ...
Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...
A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...
A new pill to treat metastatic pancreatic cancer, daraxonrasib, nearly doubles survival time compared to traditional chemotherapy, according to study findings presented at an American Society for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results